ClinConnect ClinConnect Logo
Search / Trial NCT05674734

4FM Acceptance Training as the New Form of cPTSD-focused Treatment Based on Existential Analysis

Launched by INSTITUTE OF PSYCHIATRY AND NEUROLOGY, WARSAW · Dec 29, 2022

Trial Information

Current as of November 11, 2025

Not yet recruiting

Keywords

C Ptsd Complex Trauma Treatment 4 Fundamental Motivations Existential Analysis

ClinConnect Summary

This clinical trial is studying a new therapy called 4FM Acceptance training, designed to help people with complex post-traumatic stress disorder (cPTSD) that might stem from relational trauma. The research aims to validate a Polish version of a questionnaire used to assess trauma, understand how common relational trauma is among adults in a psychiatric hospital, develop the 4FM Acceptance training based on a psychological approach called Existential Analysis, and evaluate how effective this new therapy is for patients with cPTSD.

To participate in the trial, individuals must be between the ages of 18 and 65, speak Polish, and have a stable mental state that allows them to complete questionnaires accurately. They also need to be diagnosed with cPTSD based on the questionnaire being used. Participants will be expected to provide their consent to join the study and undergo the new therapy, which aims to improve their mental health. It's important to note that individuals with certain conditions, like substance addictions or severe cognitive impairments, are not eligible to participate.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Signed informed consent provide.
  • 2. Stable mental state allowing for reliable completion of the questionnaires.
  • 3. Native Polish language.
  • 4. Meeting the cPTSD diagnosis based on ITQ - International Trauma Questionnaire), self-report questionnaire, Cloitre et al. (2021), Polish version validated within the project.
  • Exclusion Criteria:
  • 1. No consent to participate in the research.
  • 2. Coexisting addiction to alcohol or psychoactive substances, documented intellectual disability, dementia or organic changes of the central nervous system.

About Institute Of Psychiatry And Neurology, Warsaw

The Institute of Psychiatry and Neurology in Warsaw is a leading research institution dedicated to advancing the understanding and treatment of mental health and neurological disorders. Renowned for its commitment to clinical research, the institute focuses on innovative therapeutic approaches and evidence-based practices, fostering collaboration among multidisciplinary teams of experts in psychiatry, neurology, and related fields. By conducting rigorous clinical trials, the institute aims to enhance patient care and contribute to the global body of knowledge in mental health and neuroscience, positioning itself as a pivotal player in the advancement of psychiatric and neurological health.

Locations

Patients applied

0 patients applied

Trial Officials

Dorota Draczyńska

Principal Investigator

Institute of Psychiatry and Neurology

Marta Anczewska, prof.

Study Director

Institute of Psychiatry and Neurology

Agnieszka Nowakowska, PhD

Study Chair

Nowowiejski Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials